- Bonso Electronics International Inc. (BNSO): Important & Key Factors of Technology Stock
- What's the Analyst Recommendation for PhaseBio Pharmaceuticals Inc. (PHAS)?
- Alliance Resource Partners L.P. (ARLP): Important & Key Factors of Energy Stock
- AeroCentury Corp. (ACY) Plunged -11.39%, Can Traders Take Benefit?
- Pixelworks Inc. (PXLW): Important & Key Factors of Technology Stock
Dougherty & Company announced it was Reiterated coverage of Apyx Medical Corporation in a research note on April 02, 2019. The analysts assigned a Buy rating to the stock with a price target of $9.
Goodwin Charles D. II, the Chief Executive Officer of Apyx Medical Corporation, bought 28250.0 shares at the valuation of $3.30 during an exchange that occurred on May 13, which implies that Goodwin Charles D. II is holding 28,250 shares at the estimation of $93,197 dependent on the most recent closing price.
APYX Recent Trade
The share price of APYX ascended by $0.17 during the exchanging session on 07/10/20 to exchange at $4.78. Apyx Medical Corporation stock has an exchanging volume of 64164.0 shares, which is low, contrasted with its 3-months average volume of 136.32K shares. Its market capitalization has now reached to $157.60M and analysts have a consensus target price of $7.75 in the 12-month period.
APYX Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, APYX price has dropped by -11.81%. In the course of past three months sees the stock go up around 20.40%, while it has lost -40.99% over the past six months and -43.50% since the start of the year.
APYX Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jun 2020), the firm recorded a revenue of 5.0 billion, which was higher than the gauge of 1.96M made by certain experts. For that equivalent quarter, Apyx Medical Corporation posted -$0.06 earnings per share (EPS) which was above the consensus estimate of -$0.25 by $0.19, which represents to an expansion by 76.00%.
APYX Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Apyx Medical Corporation has seen its stock exchanging -21.87% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +70.41% above its three-month low. A more extensive look sees APYX exchanging -44.35% beneath its 52-week high and 70.41% above from its 52-week low price.
APYX Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 6.41%, while it has a month to month instability of 8.58%. The company has an ATR (Average True Range) of 0.43 and a beta factor of 0.81.